News and Events

Lecture: TGF-beta Receptor Signaling in Breast Cancer Progression

药学院英文网站   发布时间: 2017-09-21   信息员:    浏览次数: 112

Lecture: TGF-beta Receptor Signaling in Breast Cancer Progression


Lecturer: Prof.Peter ten Dijke, Leiden University Medical Center,



Peter ten Dijke received his Ph.D. degree in 1991 from Wageningen University, The Netherlands based on his research on the identification of the third isoform of TGFβ performed at Oncogene Science, Inc., New York, USA. He did his postgraduate studies with KoheiMiyazono and Carl-HenrikHeldin at the Ludwig Institute for Cancer Research (LICR), Uppsala, Sweden. In 1994, he became group leader at LICR and in 1999 he moved to the Netherlands Cancer Institute, Amsterdam, The Netherlands. In 2005 he moved to the Leiden University Medical Center, Leiden, The Netherlands, and is currently a professor of molecular cell biology at Leiden University. His laboratory studies the molecular mechanisms by which TGFβ family members elicit their cellular effects via (co)receptors and intracellular SMAD effectors, and how subverted TGF family signaling is involved in cancer, vascular and bone diseases


Venue: Room 426, Zhuangjin Building

Time: 2017-09-25 14:00

Copyright©2011 School of Pharmaceutical Sciences Xiamen University All Rights Reserved